Page 126 – ORTHOWORLD

Spineart Completes Enrollment for Baguera-C 2-Level Disc Trial

The U.S. IDE trial will study the Baguera-C Disc in patients with cervical disc disease at two contiguous levels....

Mar 08, 2024, Julie Vetalice

We gathered quotes from top orthopedic executives as they reflected on enabling technology, procedure demand and M&A integration progress. ...

Mar 07, 2024, Mike Evers

HydroPutty bone graft features hydrophilic carriers designed to absorb fluids such as bone marrow aspirate, blood or saline....

Mar 07, 2024, Julie Vetalice

Sonex launched a clinical registry to collect real-world data on patients treated with carpal tunnel release using ultrasound guidance....

Mar 07, 2024, Julie Vetalice

The company grew in the mid-single-digits on a pro forma basis in 2023 and is focused on leveraging its...

Mar 06, 2024, Mike Evers

CERAMENT bone void filler is an injectable, moldable and drillable synthetic bone void filler comprising hydroxyapatite and calcium sulfate....

Mar 06, 2024, Julie Vetalice

This is the company's first solution to treat Early Onset Scoliosis patients, specifically those associated with or at risk of...

Mar 05, 2024, Julie Vetalice

Bone Biologics is focusing development of a bone graft substitute for bone regeneration in spinal fusion procedures, while additionally having...

Mar 05, 2024, Julie Vetalice

The company grew 19% in 2023 despite contending with supply chain constraints and could growth another 20% in 2024....

Mar 04, 2024, Mike Evers

The company's MACI revenues grew nearly 25% in 2023 and Vericel expects the launch of MACI Arthro in the third...

Mar 04, 2024, Mike Evers